BeStock  
Markets › Compare › LNTH vs SUPN

LNTH vs SUPN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
LNTH · Lantheus$102.10 ▲ 0.00%
SUPN · Supernus Pharmaceuticals$28.61 ▲ 0.92%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5088127166205Nov 24, '25May 26, '26Nov 20, '26
  • LNTH +80.7%
  • SUPN -36.6%

Head to head

MetricLNTHSUPN
Price$102.10$28.61
Change today▲ 0.00%▲ 0.92%
Market cap$6.68B$5.94B
Return, 3 months+1.3%-36.6%
Return, year to date+53.4%-42.4%
Return, 1 year+82.9%-36.9%
P/E (TTM)25.4–
P/B4.95.6
P/E percentile vs own 5y68th20th
Dividend yield––
Revenue growth (YoY, latest qtr)+1.5%+18.0%
Net profit growth (YoY)-19.4%+146.4%
Gross margin61.3%87.6%
Operating margin18.6%3.2%
Net margin17.3%-5.1%
Return on equity21.8%-4.2%
Analyst target vs. price+5.0%+83.9%
Analyst buy share0%83%
RSI (14)6936
30-day volatility4.1%127.6%
Max drawdown, 1 year-12.2%-53.6%
Trend readStrong uptrendStrong downtrend
Analyst consensusHoldBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • LNTH is the largest of the group by market value.
  • LNTH has returned the most over the past year.
  • SUPN is growing revenue fastest.
  • LNTH keeps the most profit per dollar of sales.
  • LNTH has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top